Weinstock Jonathan
Department of Medicine, Division of Cardiology, Tufts University School of Medicine, Cardiac Arrhythmia Center, Tufts Medical Center, 800 Washington Street, Boston, MA 02118, USA.
Card Electrophysiol Clin. 2018 Mar;10(1):11-16. doi: 10.1016/j.ccep.2017.11.002.
The wearable cardioverter defibrillator has been shown to be effective in terminating ventricular arrhythmias in patients at risk for sudden cardiac death. There are numerous scenarios in which implant of a permanent implantable cardioverter defibrillator is temporarily contraindicated or not advisable and a wearable cardioverter defibrillator may be beneficial. There are no prospective randomized studies published that provide conclusive guidance toward the use of the wearable cardioverter defibrillator, and thus, patient management needs to be individualized based on the available data.
可穿戴式心脏复律除颤器已被证明在终止有心脏性猝死风险患者的室性心律失常方面是有效的。在许多情况下,永久性植入式心脏复律除颤器的植入暂时是禁忌的或不可取的,而可穿戴式心脏复律除颤器可能有益。目前尚无已发表的前瞻性随机研究为可穿戴式心脏复律除颤器的使用提供确凿的指导,因此,需要根据现有数据对患者进行个体化管理。